Therapeutic Window for Use of Hyperbaric Oxygenation in Focal Transient Ischemia in Rats

Stroke

Volumn 35, Issue 2, 2004, Pages 578-583

  Lou, Min ^a,b   Eschenfelder, Christoph Cyrill ^a   Herdegen, Thomas ^a   Brecht, Stephan ^a   Deuschl, Günther ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Animal models; Cerebral infarction; Hyperbaric oxygenation; Ischemia middle cerebral artery occlusion; Outcome; Rats; Time factors

Indexed keywords

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CLINICAL FEATURE; CONTROLLED STUDY; EVALUATION; EXPERIMENTAL MODEL; HISTOPATHOLOGY; HYPERBARIC OXYGEN; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NEUROPROTECTION; NONHUMAN; OUTCOMES RESEARCH; PRIORITY JOURNAL; RAT; TECHNIQUE; TIME; TISSUE INJURY; TRANSIENT ISCHEMIC ATTACK;

ANIMALS; BLOOD GAS ANALYSIS; BRAIN; CEREBROVASCULAR CIRCULATION; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HYPERBARIC OXYGENATION; INFARCTION, MIDDLE CEREBRAL ARTERY; ISCHEMIC ATTACK, TRANSIENT; MALE; NEUROLOGIC EXAMINATION; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TREATMENT OUTCOME;

EID: 0842310782     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000111599.77426.A0     Document Type: Article

References (22)

1. Sheffield PJ. Measuring tissue oxygen tension: a review. Undersea Hyperb Med. 1998;25:179-188.
2. Nairn JR, Power GG, Hyde RW, Forster RE, Lambertsen CJ. Dickson J. Diffusing capacity and pulmonary capillary blood flow at hyperbaric pressures. J Clin Invest. 1965;44:1591-1599.
3. Elinskii MP, Rafikov AM, Ivanova NE, Kesaev SA. Therapeutic use of hyperbaric oxygenation in ischemic strokes [in Russian]. Zh Nevropatol Psikhiatr Im S S Korsatkova. 1984;84:1321-1325.
4. Berrouschot J, Schwab S, Schneider D, Hacke W. Hyperbaric oxygen therapy (HBO) after acute focal cerebral ischemia [in German]. Nervenarzt. 1998;69:1037-1044.
5. Iwatsuki N, Takahashi M, Ono K, Tajima T. Hyperbaric oxygen combined with nicardipine administration accelerates neurologic recovery after cerebral ischemia in a canine model. Crit Care Med. 1994;22:858-863.
6. Weinstein PR, Anderson GG, Telles DA. Results of hyperbaric oxygen therapy during temporary middle cerebral artery occlusion in unanesthetized cats. Neurosurgery. 1987;20:518-524.
7. Shiokawa O, Fujishima M, Yanai T, Ibayashi S, Ueda K, Yagi H. Hyperbaric oxygen therapy in experimentally induced acute cerebral ischemia. Undersea Biomed Res. 1986;13:337-344.
8. Kawamura S, Yasui N, Shirasawa M, Fukasawa H. Therapeutic effects of hyperbaric oxygenation on acute focal cerebral ischemia in rats. Surg Neurol. 1990;34:101-106.
9. Hjelde A, Hjelstuen M, Haraldseth O, Martin D, Thom R, Brubakk O. Hyperbaric oxygen and neutrophil accumulation/tissue damage during permanent focal cerebral ischaemia in rats. Eur J Appl Physiol. 2002;86: 401-405.
10. Singhal AB, Dijkhuizen RM, Rosen BR, Lo EH. Normobaric hyperoxia reduces MRI diffusion abnormalities and infarct size in experimental stroke. Neurology. 2002;58:945-952.
11. Ruiz E, Brunette DD, Robinson EP, Tomlinson MJ, Lange J, Wieland MI, Sherman R. Cerebral resuscitation after cardiac arrest using hetastarch hemodilution, hyperbaric oxygenation and magnesium ion. Resuscitation. 1986;14:213-223.
12. Badr AE, Yin W, Mychaskiw G, Zhang JH. Dual effect of HBO on cerebral infarction in MCAO rats. Am J Physiol. 2001;280:R766-R770.
13. Sunami K, Takeda Y, Hashimoto M, Hirakawa M. Hyperbaric oxygen reduces infarct volume in rats by increasing oxygen supply to the ischemic periphery. Crit Care Med. 2000;28:2831-2836.
14. Veltkamp R, Warner DS, Domoki F, Brinkhous AD, Toole JF, Busija DW. Hyperbaric oxygen decreases infarct size and behavioral deficit after transient focal cerebral ischemia in rats. Brain Res. 2000;853:68-73.
15. Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989;20: 84-91.
16. Schabitz WR, Sommer C, Zoder W, Kiessling M, Schwaninger M, Schwab S. Intravenous brain-derived neurotrophic factor reduces infarct size and counterregulates Bax and Bcl-2 expression after temporary focal cerebral ischemia. Stroke. 2000;31:2212-2217.
17. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke. 1986;17:472-476.
18. Garcia JH, Wagner S, Liu KF, Hu XJ. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats: statistical validation. Stroke. 1995;26:627-634; comment 635.
19. Schmid-Elsaesser RZS, Hungerhuber E, Baethmann A, Reulen HJA. Critical reevaluation of the intraluminal thread model of focal cerebral ischemia: evidence of inadvertent premature reperfusion and subarachnoid hemorrhage in rats by laser-Doppler flowmetry. Stroke. 1998;29: 2162-2170.
20. Anderson DC, Bottini AG, Jagiella WM, Westphal B, Ford S, Rockswold GL, Loewenson RB. A pilot study of hyperbaric oxygen in the treatment of human stroke. Stroke. 1991;22:1137-1142.
21. Pulsinelli W. Pathophysiology of acute cerebral ischemia. Lancet. 1992; 359:533-536.
22. Murakami K, Kondo T, Kawase M, Li Y, Sato S, Chen SF, Chan PH. Mitochondrial susceptibility to oxidative stress exacerbates cerebral infarction that follows permanent focal cerebral ischemia in mutant mice with manganese superoxide dismutase deficiency. J Neurosci. 1998;18: 205-213.